Drug class
HIV-1 protease inhibitor prodrug; antiretroviral agent
Mechanism of action
Fosamprenavir is a phosphate prodrug that is hydrolysed to amprenavir. Amprenavir inhibits HIV-1 protease, preventing cleavage of viral gag-pol polyproteins and production of mature infectious virions.
General use cases
- Treatment of HIV-1 infection in combination with other antiretroviral agents in adults and eligible paediatric patients; current use depends on resistance profile, drug interactions and national treatment guidelines
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
